Go to Polygence Scholars page
Minnila Muthukumar's cover illustration
Polygence Scholar2022
Minnila Muthukumar's profile

Minnila Muthukumar

Kingswood Oxford SchoolClass of 2024Glastonbury, Connecticut


Hello! My name is Minnila, and I am researching CRISPR-Cas9 technology and its successes in cancer therapy. I chose this project because CRISPR as a whole is quite interesting to me.


  • "CRISPR-Cas9’s Successes in Cancer Therapy" with mentor Olivia (Sept. 6, 2022)

Project Portfolio

CRISPR-Cas9’s Successes in Cancer Therapy

Started Apr. 15, 2022

Abstract or project description

This paper falls under the categories of Biology and Genetics. It covers the following topics: genes, gene editing, cancer, tumors/tumor growth, cancer drugs, and more. Overall, this paper focuses on talking about CRISPR-Cas9 technology, including what it is, how it works, its various components, and how it is useful in discovering information about tumor growth. Then, the paper talks about different types of cancers in which CRISPR-Cas9 has had major successes, including the problem that CRISPR-Cas9 had to solve and how it solved/aided in solving the problem.

Cancer is a deadly illness that is the 2nd leading cause of death in the United States. As a whole, cancer is a complex disease that has various strains, types, and forms. Cancer forms when mutations (such as chromosome duplications or deletions) occur in cells, creating a cancerous cell that lacks the basic functions that normal cells have. These cells completely change their gene expression and stop functioning normally. CRISPR is an extremely powerful and flexible tool that can be used to analyze specific genes in cancer to understand the effects of one gene on all of the others. It has had a huge impact on understanding and treating cancers, and has allowed many scientists to have major breakthroughs in cancer research. While cancer is a dangerous illness with no real cure, scientists are working hard to understand cancer as a whole, and CRISPR-Cas9 has played a huge part in the discovery of new information, treatments, and more. It is clear that CRISPR is essential to understanding and treating cancer and its various strains. While CRISPR is still young, it has affected almost all aspects of cancer and has become a crucial tool used by scientists and researchers alike. Overall, CRISPR-Cas9’s advances and successes have proven that it will continue to be a key tool in cancer therapy.